ELEDON PHARMACEUTICALS, INC.

IRVINE, CA How do I update this listing?

Eledon Pharmaceuticals is based out of Irvine. Novus Therapeutics, Inc. operates as a pharmaceutical company. The Company provides acquisition, development, and commercialization of medicinal products for ear, nose, and throat disorders. Novus Therapeutics serves customers in the United States. Whalewisdom has at least 92 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-09-25. The notice included securities offered of Equity

Create Alert

Contact Info

eledon pharmaceuticals, inc.
19900 MACARTHUR BLVD.
IRVINE CA    92612

Business Phone: 949-238-8090
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-09-25 D BIOTECHNOLOGY Equity 108,144,151 108,144,151 0
2020-01-27 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,828,999 862,278 4,966,721
2019-05-10 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 28,455,174 862,278 27,592,896
2013-05-15 D BIOTECHNOLOGY Equity 35,499,985 19,999,993 15,499,992
2011-09-20 D BIOTECHNOLOGY Equity 22,999,986 1,892,794 21,107,192
2009-05-06 D BIOTECHNOLOGY Equity 22,000,000 10,000,000 12,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CAMPBELL MURRAY subscription required
    DIRECTOR
CATHERINE TURKEL subscription required
    EXECUTIVE OFFICER
CHERYL COHEN subscription required
    DIRECTOR
DAVID KESSLER subscription required
    DIRECTOR
DAVID-ALEXANDRE GROS subscription required
    EXECUTIVE OFFICER DIRECTOR
EREZ CHIMOVITS subscription required
    DIRECTOR
GARY LYONS subscription required
    DIRECTOR
GREGORY FLESHER subscription required
    EXECUTIVE OFFICER DIRECTOR
JODIE P. MORRISON subscription required
    EXECUTIVE OFFICER
JOHN MCBRIDE subscription required
    DIRECTOR
JON KUWAHARA subscription required
    EXECUTIVE OFFICER
JOSEPH A. YANCHIK, III subscription required
    DIRECTOR
KEITH KATKIN subscription required
    DIRECTOR
REINHARD AMBROS subscription required
    DIRECTOR
SCOTT CHAPPEL subscription required
    EXECUTIVE OFFICER
SETH L. HARRISON subscription required
    EXECUTIVE OFFICER DIRECTOR
STEVEN N. PERRIN subscription required
    DIRECTOR
TIMOTHY BARBERICH subscription required
    DIRECTOR
WALTER OGIER subscription required
    DIRECTOR

Elevate your investments